01 Identity
Registration and reporting
- Registration status
- Registered
- Reporting status
- New
- Charity type
- CIO
- Registered
- 21 May 2026
- Removed
- Not supplied
- Financial period
- Not supplied – Not supplied
- Latest income
- Not supplied
- Latest expenditure
- Not supplied
- In administration
- No
- Insolvent
- No
- CIO
- Yes
03 Official extract
Charity Area Of Operation
- Geographic Area Type
- Region
- Geographic Area Description
- Throughout England And Wales
- Welsh Ind
- No
- Geographic Area Type
- Country
- Geographic Area Description
- Scotland
- Parent Geographic Area Type
- Continent
- Parent Geographic Area Description
- Europe
- Welsh Ind
- No
- Geographic Area Type
- Country
- Geographic Area Description
- Northern Ireland
- Parent Geographic Area Type
- Continent
- Parent Geographic Area Description
- Europe
- Welsh Ind
- No
04 Official extract
Charity Classification
- Classification Code
- 103
- Classification Type
- What
- Classification Description
- The Advancement Of Health Or Saving Of Lives
- Classification Code
- 307
- Classification Type
- How
- Classification Description
- Provides Advocacy/advice/information
- Classification Code
- 207
- Classification Type
- Who
- Classification Description
- The General Public/mankind
- Classification Code
- 308
- Classification Type
- How
- Classification Description
- Sponsors Or Undertakes Research
05 Official extract
Charity Event History
- Charity Name
- THE TOM TOWLER EBV-HLH CHARITY
- Charity Event Order
- 1
- Event Type
- CIO registration
- Date Of Event
- 2026-05-21T00:00:00
06 Official extract
Charity Governing Document
- Governing Document Description
- CIO - FOUNDATION Registered 21 May 2026
- Charitable Objects
- THE OBJECTS OF THE CIO ARE, FOR THE PUBLIC BENEFIT, THE RELIEF OF SICKNESS AND THE PRESERVATION OF HEALTH AMONG PATIENTS AFFECTED BY THE EPSTEIN?BARR VIRUS-ASSOCIATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS ("EBV-HLH"), THEIR FAMILIES AND CARERS, IN PARTICULAR BUT NOT EXCLUSIVELY BY:A. THE PROMOTION AND FURTHERANCE OF SCIENTIFIC RESEARCH INTO THE PHYSIOLOGY AND PATHOLOGY OF EBV-HLH AND THE AETIOLOGY OF EBV-HLH DISEASE, THE USEFUL RESULTS OF WHICH WILL BE DISSEMINATED FOR THE BENEFIT OF THE PUBLIC; B. THE DEVELOPMENT OF MORE ACCURATE MEANS OF DIAGNOSIS, IMPROVED PROTOCOLS FOR MANAGEMENT OF PATIENTS AND ULTIMATELY MEASURES FOR PREVENTION OF EBV-HLH DISEASE; C. THE PROVISION AND DISSEMINATION OF INFORMATION, EDUCATION AND KNOWLEDGE IN SUPPORT OF PATIENTS AND FAMILIES AFFECTED BY EBV-HLH DISEASE TO INCLUDE ALL OR ANY MEDICAL PROFESSIONALS AND THE GENERAL PUBLIC; ANDD. COLLABORATION WITH INTERESTED INDIVIDUALS AND ORGANISATIONS.